Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
Titel:
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
Auteur:
Kuemmel, Sherko Graeser, Monika Schmid, Peter Reinisch, Mattea Feuerhake, Friedrich Volk, Valery Armeanu-Ebinger, Sorin Schütz, Leon Kelemen, Olga Schroeder, Christopher Ossowski, Stephan Jóźwiak, Katarzyna Kostara, Athina Scheffen, Iris Lüdtke-Heckenkamp, Kerstin Hilpert, Felix Kentsch, Angela Ziske, Carsten Depenbusch, Reinhard Braun, Michael Blohmer, Jens Uwe zu Eulenburg, Christine Christgen, Matthias Bartels, Stephan Kreipe, Hans Heinrich Wuerstlein, Rachel Biehl, Claudia Pelz, Enrico Hartkopf, Andreas Harbeck, Nadia Gluz, Oleg